𝔖 Bobbio Scriptorium
✦   LIBER   ✦

VAB-6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis

✍ Scribed by Davor Vugrin; Willet F. Whitmore Jr.; Robert B. Golbey

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
543 KB
Volume
51
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

VAB–4 combination chemotherapy in the tr
VAB–4 combination chemotherapy in the treatment of metastatic testis tumors
✍ Davor Vugrin; Esteban Cvitkovic; Willet F. Whitmore Jr.; Edgar Cheng; Robert B. πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 632 KB

Forty-two patients with advanced testis carcinoma without previous chemotherapy were treated with VAB-4, and 41 were evaluable. The program consisted of three in-hospital inductions 16 weeks apart, and outpatient treatments every three weeks. Of the patients, 80% achieved complete remissions (CR). C

Combination chemotherapy in the treatmen
Combination chemotherapy in the treatment of advanced breast cancer
✍ Dutzu Rosner; Takuma Nemoto; Chief Thomas L. Dao πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 289 KB

## Abstract Seventy‐two women with metastatic breast cancer were treated with multiple‐agent chemotherapy. Fifty women were treated with 5 drugs in combination: 5‐FU, methotrexate, vincristine, cytoxan, and prednisone; 22 were treated with the combination of 3 drugs: 5‐FU, cytoxan, and prednisone.

Combination chemotherapy plus BCG in the
Combination chemotherapy plus BCG in the treatment of disseminated malignant melanoma: A southwest oncology group study
✍ Costanzi, John J. ;Al-Sarraf, Muhyi ;Groppe, Carl ;Bottomley, Richard ;Fabian, C πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 466 KB

## Abstract The Southwest Oncology Group performed a randomized study comparing combination chemotherapy alone versus combination chemotherapy plus BCG versus DTIC plus BCG in the treatment of disseminated malignant melanoma. A 31% response rate was noted with combination chemotherapy alone, a 27%